English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
Vivani Medical GLP-1植入剂临床试验取得进展
与此同时,Vivani已在澳大利亚开始了LIBERATE-1临床试验,用于其艾塞那肽植入剂,这标志着肥胖治疗的重大进展。该试验将评估植入剂的安全性、耐受性和药代动力学,预计将于2025年年中获得初步数据。H.C.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Senate passes funding bill
Sworn in as Canada's PM
Second protester arrested
Texas measles outbreak
Strikes deal with DOGE
Laceration hazard recall
Pleads not guilty
Plane engine catches fire
Consumer sentiment drops
Permanently shuts route
‘Ted Lasso’ is coming back
Visits DOJ for speech
Court lifts Trump's DEI block
Gold rises to new heights
Wins longest-ever Iditarod
Coffee creamer recall
Influential WY senator dies
Senate confirmation hearing
Child abuse images sentence
Massive dust storms in Texas
SpaceX launches Crew-10
Influencer leaves Australia
Legendary sportswriter dies
Hamas to release hostage
Man hit by motorcade, dies
Teixeira pleads guilty
To cut 2,000+ jobs
March megastorm
反馈